Latest Insights - page 25 | BiopharmaTrend

H1 2025 Recap: Key Signals from the Tech+Bio Frontier

A high-signal summary of some of the most important moves and trends shaping biotech and tech-enabled life sciences in the first half of 2025. In this issue: Financial Climate & …

Continue ›››

Neuralink Begins UK Clinical Trial of Brain Implant for People with Paralysis

Neuralink, Elon Musk’s brain computer interface (BCI) developing company, has launched its first clinical trial in the UK to evaluate the safety and functionality of its N1 brain-computer interface (BCI) …

Continue ›››

OpenAI-Backed Ambience Raises $243M in Series C, Reaching $1B+ Valuation

San Francisco-based AI startup Ambience Healthcare has raised $243 million in Series C funding, bringing its valuation to over $1 billion, according to Bloomberg. The round was co-led by Andreessen …

Continue ›››

Profluent Publishes AI-Designed Genome Editor in Nature, Releases Largest CRISPR Dataset

Profluent, an AI-first protein design company founded in 2022 in Berkeley, CA, has published research in Nature on OpenCRISPR-1, an AI-designed genome editor capable of editing the human genome. The …

Continue ›››

AI-Native Formation Bio Licenses Monoclonal Antibody After $372M Raise in 2024

Formation Bio has licensed global rights to a first-in-class anti-CD226 monoclonal antibody from IMIDomics, aiming to expand its immunology pipeline with a Phase 1–ready program for autoimmune diseases. The program’s …

Continue ›››

"AI Scientists" - New Collaborators for Rare Disease Research?

In the quest to understand and treat the over 6,000 rare diseases, researchers encounter a number of limitations – in the amount of available data, access to interdisciplinary expertise, and …

Continue ›››

Modi Ventures Closes $88M Second Fund for AI–Biology Convergence Investments

Modi Ventures has raised $88 million for its second fund, bringing total committed capital to over $134 million. The Houston-based venture firm, launched in 2022, invests in companies and funds …

Continue ›››

Latent Labs Launches Web-Based AI Tool for Custom Protein Generation

Five months after emerging from stealth with $50 million in funding, Latent Labs has launched a web-based AI model Latent-X for programmable protein design. The release marks a shift from closed, proprietary …

Continue ›››

UK Rolls Out National Strategy to Build Europe’s Life Sciences Powerhouse by 2030

The UK government has released a new Industrial Strategy white paper outlining plans to strengthen the country’s life sciences sector. Building on the previous green paper and industry consultations, the …

Continue ›››

What are Foundation Models in Biology and Healthcare?

Content: History of AI in the Context of Foundation Models The Technology Stack Behind Foundation Models The Paradigm Shift in Biomedical Research and Drug Discovery Challenges of Foundation Models in …

Continue ›››

How Organoids and AI Are Replacing Animal Testing

As FDA & NIH formalize support for non-animal testing, organ-on-a-chip, organoids, and ML-based toxicity models are being integrated into preclinical workflows by both startups and established pharma. On April 10th, …

Continue ›››

Japan’s Elix Launches AI Drug Discovery Platform Trained on Confidential Pharma Data via Federated Learning

Tokyo-based Elix (founded 2016) has launched Elix Discovery, an AI drug discovery platform powered by federated learning models trained on proprietary compound data from 16 pharmaceutical companies. The platform is …

Continue ›››